Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

β-Cyclodextrins as affordable antivirals to treat coronavirus infection

  • Raïch-Regué, Dàlia|||0000-0001-7656-5700
  • Tenorio, Raquel
  • Fernández de Castro, Isabel
  • Tarrés-Freixas, Ferran|||0000-0002-1569-0126
  • Sachse, Martin
  • Perez-Zsolt, Daniel|||0000-0003-4192-7622
  • Muñoz-Basagoiti, Jordana|||0000-0002-0384-5928
  • Fernández-Sánchez, Sara Y.
  • Gallemí, Marçal|||0000-0003-4675-6893
  • Ortega-González, Paula
  • Fernández-Oliva, Alberto
  • Gabaldón, José A.
  • Nuñez-Delicado, Estrella
  • Casas, Josefina|||0000-0002-7926-5209
  • Roca, Núria
  • Cantero, Guillermo|||0000-0003-4200-503X
  • Pérez, Mónica
  • Usai, Carla|||0000-0002-6373-2765
  • Lorca-Oró, Cristina|||0000-0001-5351-4169
  • Vergara-Alert, Júlia|||0000-0001-7484-444X
  • Segalés Coma, Joaquim|||0000-0002-1539-7261
  • Carrillo, Jorge|||0000-0003-0221-5948
  • Blanco, Julià|||0000-0002-2225-0217
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Cerón-Carrasco, José P.
  • Izquierdo Useros, Nuria|||0000-0002-1039-1821
  • Risco, Cristina|||0000-0001-7501-5934
The SARS-CoV-2 pandemic made evident that there are only a few drugs against coronavirus. Here we aimed to identify a cost-effective antiviral with broad spectrum activity and high safety profile. Starting from a list of 116 drug candidates, we used molecular modelling tools to rank the 44 most promising inhibitors. Next, we tested their efficacy as antivirals against α and β coronaviruses, such as the HCoV-229E and SARS-CoV-2 variants. Four drugs, OSW-1, U18666A, hydroxypropyl-β-cyclodextrin (HβCD) and phytol, showed in vitro antiviral activity against HCoV-229E and SARS-CoV-2. The mechanism of action of these compounds was studied by transmission electron microscopy and by fusion assays measuring SARS-CoV-2 pseudoviral entry into target cells. Entry was inhibited by HβCD and U18666A, yet only HβCD inhibited SARS-CoV-2 replication in the pulmonary Calu-3 cells. Compared to the other cyclodextrins, β-cyclodextrins were the most potent inhibitors, which interfered with viral fusion via cholesterol depletion. β-cyclodextrins also prevented infection in a human nasal epithelium model ex vivo and had a prophylactic effect in the nasal epithelium of hamsters in vivo. All accumulated data point to β-cyclodextrins as promising broad-spectrum antivirals against different SARS-CoV-2 variants and distant alphacoronaviruses. Given the wide use of β-cyclodextrins for drug encapsulation and their high safety profile in humans, our results support their clinical testing as prophylactic antivirals.